HETEROGENEITY OF THE 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE EFFICACY DUE TO VARIOUS UNDERLYING CONDITIONS OF CHRONIC PULMONARY DISEASE IN ELDERLY PATIENTS

被引：0
|
作者：
Inoue, S. [1 ]
Kaneko, T. [2 ]
Morita, S. [2 ]
Natsumeda, Y. [3 ]
Mizushima, S. [1 ]
机构：
[1] Yokohama City Univ, Grad Sch Med, Dept Epidemiol & Publ Hlth, Yokohama, Kanagawa 232, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan
[3] Yokohama City Univ, Grad Sch Med, Lab Clin Res, Yokohama, Kanagawa 232, Japan
来源：
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH | 2011年 / 65卷
关键词：
D O I：
10.1136/jech.2011.142976d.71
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：A115 / A115
页数：1
相关论文
共 50 条
  • [41] The Serological Response Of Asthmatics To The 23-Valent Pneumococcal Polysaccharide Vaccine (ppsv23)
    Laratta, C. R.
    Williams, K.
    Vethanayagam, D.
    Ulanova, M.
    Vliagoftis, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [42] Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children
    Sigurdardottir, Sigurveig Th.
    Center, Kimberly J.
    Davidsdottir, Katrin
    Arason, Vilhjalmur A.
    Hjalmarsson, Bjorn
    Elisdottir, Ragnheidur
    Ingolfsdottir, Gunnhildur
    Northington, Robert
    Scott, Daniel A.
    Jonsdottir, Ingileif
    VACCINE, 2014, 32 (03) : 417 - 424
  • [43] The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: A comparison of meta-analyses
    Melegaro A.
    Edmunds W.J.
    European Journal of Epidemiology, 2004, 19 (4) : 353 - 363
  • [44] Cost-effectiveness of a 23-valent pneumococcal polysaccharide vaccine immunization programme for the elderly in Shanghai, China
    Zhao, Daijun
    Tobe, Ruoyan Gai
    Cui, Min
    He, Jinchun
    Wu, Bin
    VACCINE, 2016, 34 (50) : 6158 - 6165
  • [45] Revaccination with 23-valent pneumococcal polysaccharide vaccine in the Japanese elderly is well tolerated and elicits immune responses
    Kawakami, Kenji
    Kishino, Hiroyuki
    Kanazu, Shinichi
    Toshimizu, Nobuhito
    Takahashi, Kenichi
    Sterling, Tina
    Wang, Meihua
    Musey, Luwy
    VACCINE, 2016, 34 (33) : 3875 - 3881
  • [46] Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in elderly residents of a long-term care facility
    Valenzuela B., M. Teresa
    Altuzarra H., Rogelio
    Trucco A., Olivia
    Villegas R., Rodrigo
    Inostroza S., Jaime
    Granata S., Paulo
    Fleiderman V., Jose
    Maggi C., Leonardo
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (03): : 322 - 326
  • [47] The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: A comparison of meta-analyses
    Melegaro, A
    Edmunds, WJ
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2004, 19 (04) : 353 - 363
  • [48] Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population:: The EVAN-65 Study
    Vila-Corcoles, Angel
    Ochoa-Gondar, Olga
    Hospital, Imma
    Ansa, Xabier
    Vilanova, Angels
    Rodriguez, Teresa
    Llor, Carl
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) : 860 - 868
  • [49] Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
    Vila-Corcoles, Angel
    Ochoa-Gondar, Olga
    Guzman, Jorge A.
    Rodriguez-Blanco, Teresa
    Salsench, Elisabet
    Fuentes, Cruz M.
    BMC INFECTIOUS DISEASES, 2010, 10
  • [50] Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
    Angel Vila-Corcoles
    Olga Ochoa-Gondar
    Jorge A Guzmán
    Teresa Rodriguez-Blanco
    Elisabet Salsench
    Cruz M Fuentes
    BMC Infectious Diseases, 10
12345